Antihistamines: do they work? Further well-controlled trials involving larger samples are needed

被引:10
作者
Fumagalli, F [1 ]
Baiardini, I [1 ]
Pasquali, M [1 ]
Compalati, E [1 ]
Guerra, L [1 ]
Massacane, P [1 ]
Canonica, GW [1 ]
机构
[1] Univ Genoa, DIMI, Genoa, Italy
关键词
antihistamines; allergic inflammation; quality of life;
D O I
10.1111/j.1398-9995.2004.00573.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Histamine is one of the most important steps in the phlogistic allergic reaction. Its activity is due to the link to specific receptors on the cellular surface. HI-receptors of second generation are the most currently prescribed drugs in allergic diseases for their high selectivity, little or no central sedative effect, rapid onset of action and long half lives. Antihistamines can modulate part of immunological mechanisms involved in the pathogenesis of allergic inflammation reducing mediator release and expression of adhesion molecules, regulating the release of cytokines, chemokines and consequently inflammatory cells recruitment. The anti-inflammatory effects of cetirizine, desloratadine and levocetirizine are reviewed. Quality of life is considered too, as a main parameter in a global evaluation of the antihistamine's effects.
引用
收藏
页码:74 / 77
页数:4
相关论文
共 32 条
[1]  
Albanesi C, 1998, CLIN EXP ALLERGY, V28, P101
[2]  
Baena-Cagnani CE, 2001, ALLERGY, V56, P21
[3]   INFLUENCE OF H-1-RECEPTOR ANTAGONISTS ON ADHESION MOLECULES AND CELLULAR TRAFFIC [J].
BAGNASCO, M ;
CANONICA, GW .
ALLERGY, 1995, 50 (24) :17-23
[4]   Treatment of acquired cold urticaria with cetirizine and zafirlukast in combination [J].
Bonadonna, P ;
Lombardi, C ;
Senna, G ;
Canonica, GW ;
Passalacqua, G .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (04) :714-716
[5]  
Dubuske LM, 2001, J ALLERGY CLIN IMMUN, V107, pS159
[6]   Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells [J].
Genovese, A ;
Patella, V ;
DeCrescenzo, G ;
DePaulis, A ;
Spadaro, G ;
Marone, G .
CLINICAL AND EXPERIMENTAL ALLERGY, 1997, 27 (05) :559-567
[7]   Inhibition of interleukin-4 and interleukin-13 release from immunologically activated human basophils due to the actions of anti-allergic drugs [J].
Gibbs, BF ;
Vollrath, IB ;
Albrecht, C ;
Amon, U ;
Wolff, HH .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (05) :573-578
[8]   A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects [J].
Grant, JA ;
Riethuisen, JM ;
Moulaert, B ;
DeVos, C .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2002, 88 (02) :190-197
[9]   Model for outcomes assessment of antihistamine use for seasonal allergic rhinitis [J].
Harvey, RP ;
Comer, C ;
Sanders, B ;
Westley, R ;
Marsh, W ;
Shapiro, H ;
Wiener, M .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (06) :1233-1241
[10]   Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells [J].
Hofstra, CL ;
Desai, PJ ;
Thurmond, RL ;
Fung-Leung, WP .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (03) :1212-1221